Puma Biotechnology (PBYI) Other Non Operating Income (2011 - 2026)
Puma Biotechnology (PBYI) reported Other Non Operating Income of $130000.0 for Q1 2026, down 63.79% on a YoY basis from $359000.0 in Q1 2025, and down 9.09% quarter-over-quarter from $143000.0 in Q4 2025.
Puma Biotechnology (PBYI) Other Non Operating Income (2011 - 2026) Analysis & Trends
Puma Biotechnology has reported Other Non Operating Income for 15 years, with the latest figure at $130000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income fell 63.79% year-over-year to $130000.0; the trailing twelve-month figure through Mar 2026 stood at $798000.0 (down 29.38% YoY), and the FY2025 full-year result was $1.0 million, up 19.14% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $130000.0, down from $143000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $641000.0 in Q4 2023, with the low at -$204000.0 in Q4 2022.
- Historically, Other Non Operating Income has averaged $161764.7 across 5 years, with a median of $115000.0 in 2025.
- Annual changes were most pronounced in 2022 — Other Non Operating Income plunged 271.43% — and 2023, when it jumped 414.22%.
- Puma Biotechnology's Other Non Operating Income stood at -$204000.0 in 2022, then jumped by 414.22% to $641000.0 in 2023, then plunged by 58.19% to $268000.0 in 2024, then tumbled by 46.64% to $143000.0 in 2025, then dropped by 9.09% to $130000.0 in 2026.
- The last three Other Non Operating Income figures came in at $130000.0 (Q1 2026), $143000.0 (Q4 2025), and $115000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Puma Biotechnology | 384.39 Mn | 282.84 Mn | 34.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 130,000.00 |
| Dec 31, 2025 | 143,000.00 |
| Sep 30, 2025 | 115,000.00 |
| Jun 30, 2025 | 410,000.00 |
| Mar 31, 2025 | 359,000.00 |
| Dec 31, 2024 | 268,000.00 |
| Sep 30, 2024 | 347,000.00 |
| Jun 30, 2024 | 156,000.00 |
| Mar 31, 2024 | 91,000.00 |
| Dec 31, 2023 | 641,000.00 |
| Sep 30, 2023 | 74,000.00 |
| Jun 30, 2023 | 86,000.00 |
| Mar 31, 2023 | -42,000.00 |
| Dec 31, 2022 | -204,000.00 |
| Sep 30, 2022 | 64,000.00 |
| Jun 30, 2022 | 62,000.00 |
| Mar 31, 2022 | 50,000.00 |
| Dec 31, 2021 | 119,000.00 |
| Sep 30, 2021 | 71,000.00 |
| Jun 30, 2021 | 60,000.00 |